These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9833679)

  • 1. Development of ET(B) selective agonists: solution structure of a linear endothelin-1 analogue, ET-1 [Cys(Acm)(1,15), Ala3, Leu7, dAsp8, Aib11].
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    J Biomol Struct Dyn; 1998 Oct; 16(2):425-35. PubMed ID: 9833679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformation of an ET(B) selective agonist, ET-1[Cys(Acm)1,15,Ala3,Leu7,Aib11], in CD3OH/H2O by 1H NMR and molecular modelling.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    FEBS Lett; 1998 Mar; 425(2):234-8. PubMed ID: 9559655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of ET(B) receptor agonists: NMR spectroscopic and conformational studies of ET7-21[Leu7, Aib11, Cys(Acm)15].
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    Protein Eng; 2002 Mar; 15(3):161-7. PubMed ID: 11932487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of a novel ETB receptor selective agonist ET1-21 [Cys(Acm)1,15, Aib3,11, Leu7] by nuclear magnetic resonance spectroscopy and molecular modelling.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    J Pept Res; 1999 Mar; 53(3):223-33. PubMed ID: 10231710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A linear endothelin-1 analogue: solution structure of ET-1[Aib1,3,11,15, Nle7] by nuclear magnetic resonance spectroscopy and molecular modelling.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    Neurochem Int; 1999 Jul; 35(1):35-45. PubMed ID: 10403428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure determination of endothelin-1 in methanol/water by NMR and molecular modelling methods.
    Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH
    J Pept Sci; 1997; 3(6):415-28. PubMed ID: 9467970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and structural characterization of long-sarafotoxins, a new family of endothelin-like peptides: Role of the C-terminus extension.
    Mourier G; Hajj M; Cordier F; Zorba A; Gao X; Coskun T; Herbet A; Marcon E; Beau F; Delepierre M; Ducancel F; Servent D
    Biochimie; 2012 Feb; 94(2):461-70. PubMed ID: 21889567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of potent peptide agonists and antagonists for the endothelin receptors.
    Cody WL; Doherty AM
    Biopolymers; 1995; 37(2):89-104. PubMed ID: 7893949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL; He JX; Reily MD; Haleen SJ; Walker DM; Reyner EL; Stewart BH; Doherty AM
    J Med Chem; 1997 Jul; 40(14):2228-40. PubMed ID: 9216842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution X-ray structure of the unexpectedly stable dimer of the [Lys(-2)-Arg(-1)-des(17-21)]endothelin-1 peptide.
    Hoh F; Cerdan R; Kaas Q; Nishi Y; Chiche L; Kubo S; Chino N; Kobayashi Y; Dumas C; Aumelas A
    Biochemistry; 2004 Dec; 43(48):15154-68. PubMed ID: 15568807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
    Forget MA; Lebel N; Sirois P; Boulanger Y; Fournier A
    Mol Pharmacol; 1996 Jun; 49(6):1071-9. PubMed ID: 8649345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.
    Andersen NH; Harris SM; Lee VG; Liu EC; Moreland S; Hunt JT
    Bioorg Med Chem; 1995 Feb; 3(2):113-24. PubMed ID: 7796045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies on endothelin receptor subtype B specific agonist IRL 1620 [suc-[Glu9, Ala11,15]ET-1(8-21)] and its analogs with dipalmitoyl phosphatidylcholine vesicles by NMR spectroscopy.
    Katahira R; Umemura I; Takai M; Oda K; Okada T; Nosaka AY
    J Pept Res; 1998 Feb; 51(2):155-64. PubMed ID: 9516051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of a monocyclic analogue of endothelin [1,15 Aba]-ET-1, determined by 1H NMR spectroscopy.
    Coles M; Munro SL; Craik DJ
    J Med Chem; 1994 Mar; 37(5):656-64. PubMed ID: 8126706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two-dimensional NMR and CD spectroscopies and constrained molecular dynamics.
    Fry DC; Madison VS; Greeley DN; Felix AM; Heimer EP; Frohman L; Campbell RM; Mowles TF; Toome V; Wegrzynski BB
    Biopolymers; 1992 Jun; 32(6):649-66. PubMed ID: 1643268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
    Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
    J Pharmacol Exp Ther; 1994 Oct; 271(1):156-63. PubMed ID: 7965709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of native disulfide bonds in endothelin-1. Structural evidence for the involvement of a highly specific salt bridge between the prosequence and the endothelin-1 sequence.
    Aumelas A; Kubo S; Chino N; Chiche L; Forest E; Roumestand C; Kobayashi Y
    Biochemistry; 1998 Apr; 37(15):5220-30. PubMed ID: 9548753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ETA and ETB binding domains using ET-derived photoprobes.
    Aubin J; Létourneau M; Francoeur E; Burgeon E; Fournier A
    Biochimie; 2008 Jun; 90(6):918-29. PubMed ID: 18343229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-activity study of a C-terminal endothelin analogue.
    Cassano E; Galoppini C; Giusti L; Hamdan M; Macchia M; Mazzoni MR; Menchini E; Pegoraro S; Rovero P
    Folia Biol (Praha); 1998; 44(1):11-4. PubMed ID: 10730869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and conformation of a model peptide of endothelin with cystine-stabilized alpha-helix motif.
    Mihara H; Tomizaki KY; Nishino N; Fujimoto T; Tamaoki H; Kobayashi Y
    Biopolymers; 1994 Jul; 34(7):963-7. PubMed ID: 8054474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.